In vitro molecular characterization of the development of the K65R and M184V mutations in subtype CHIV-1

被引：0
|
作者：
Coutsinos, D. [1 ]
Invernizzi, C. F. [1 ]
Xu, H. [1 ]
Brenner, B. G. [1 ]
Wainberg, M. A. [1 ]
机构：
[1] McGill Univ, Jewish Gen Hosp, AIDS Ctr, Montreal, PQ H3A 2T5, Canada
来源：
ANTIVIRAL THERAPY | 2007年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S127 / S127
页数：1
相关论文
共 50 条
  • [41] Antiviral activity of lamivudine in persons infected with HIV-1 that has M184V and multiple thymidine analogue mutations
    Campbell, TB
    Young, RK
    Johnson, SC
    Lanier, ER
    Kuritzkes, DR
    ANTIVIRAL THERAPY, 2003, 8 (03) : U134 - U134
  • [42] Strong decrease in viral replication capacity in HIV-1 containing both K65R and Q151M mutations
    Garcia-Perez, J.
    Perez-Olmeda, M.
    Sanchez-Palomino, S.
    Menendez-Arias, L.
    Valer, L.
    Garcia, F.
    Pumarola, T.
    Soriano, V.
    Alcami, J.
    ANTIVIRAL THERAPY, 2006, 11 (05) : S44 - S44
  • [43] Evaluation of minority populations of HIV type-1 with K103N and M184V drug resistance mutations among children in Argentina
    Vignoles, Moira
    Barboni, Graciela
    Agosti, Maria R.
    Quarleri, Jorge
    Garcia, Mariel K.
    Gonzalez Ayala, Silvia
    Salomon, Horacio
    ANTIVIRAL THERAPY, 2009, 14 (08) : 1175 - 1181
  • [44] Antiviral Activity of Tenofovir Alafenamide against HIV-1 with Thymidine Analog-Associated Mutations and M184V
    Margot, Nicolas
    Ram, Renee
    Abram, Michael
    Haubrich, Richard
    Callebaut, Christian
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (04)
  • [45] Molecular basis of antagonism between K70E and K65R tenofovir-associated mutations in HIV-1 reverse transcriptase
    Kagan, R. M.
    Lee, T.-S.
    Ross, L.
    Lloyd, R. M., Jr.
    Lewinski, M. A.
    Potts, S. J.
    ANTIVIRAL RESEARCH, 2007, 75 (03) : 210 - 218
  • [46] The M184V substitution in human immunodeficiency virus type 1 reverse transcriptase delays the development of resistance to amprenavir and efavirenz in subtype B and C clinical isolates
    Diallo, K
    Brenner, B
    Oliveira, M
    Moisi, D
    Detorio, M
    Götte, M
    Wainberg, MA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) : 2376 - 2379
  • [47] A Template-Dependent Dislocation Mechanism Potentiates K65R Reverse Transcriptase Mutation Development in Subtype C Variants of HIV-1
    Coutsinos, Dimitrios
    Invernizzi, Cedric F.
    Moisi, Daniela
    Oliveira, Maureen
    Martinez-Cajas, Jorge L.
    Brenner, Bluma G.
    Wainberg, Mark A.
    PLOS ONE, 2011, 6 (05):
  • [48] The K65R reverse transcriptase mutation in HIV-1 reverses the excision phenotype of zidovudine resistance mutations
    White, KL
    Chen, JM
    Feng, JY
    Morgot, NA
    Ly, JK
    Ray, AS
    MacArthur, HL
    McDermott, MJ
    Swaminathan, S
    Miller, MD
    ANTIVIRAL THERAPY, 2006, 11 (02) : 155 - 163
  • [49] Kinetic mechanism by which thymidine analog mutations antagonize K65R in HIV-1 reverse transcriptase
    Parikh, U
    Sluis-Cremer, N
    Mellors, J
    ANTIVIRAL THERAPY, 2005, 10 : S95 - S95
  • [50] Kinetic mechanism by which thymidine analog mutations antagonize K65R in HIV-1 reverse transcriptase
    Parikh, U
    Sluis-Cremer, N
    Mellors, J
    ANTIVIRAL THERAPY, 2005, 10 (04) : S95 - S95
12345